[go: up one dir, main page]

HK1007435A1 - Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms - Google Patents

Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms

Info

Publication number
HK1007435A1
HK1007435A1 HK98106615A HK98106615A HK1007435A1 HK 1007435 A1 HK1007435 A1 HK 1007435A1 HK 98106615 A HK98106615 A HK 98106615A HK 98106615 A HK98106615 A HK 98106615A HK 1007435 A1 HK1007435 A1 HK 1007435A1
Authority
HK
Hong Kong
Prior art keywords
protein
cytokin
microorganisms
recombinant dna
type activity
Prior art date
Application number
HK98106615A
Other languages
English (en)
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Bouteiller Christine Labit-Le
Pascal En Saint-Pier Leplatois
Marilyn Magazin
Adrian Minty
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9103904A external-priority patent/FR2674537B1/fr
Priority claimed from FR9200137A external-priority patent/FR2685919B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1007435A1 publication Critical patent/HK1007435A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
HK98106615A 1991-03-29 1998-06-25 Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms HK1007435A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9103904A FR2674537B1 (fr) 1991-03-29 1991-03-29 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
FR9200137A FR2685919B1 (fr) 1992-01-08 1992-01-08 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.

Publications (1)

Publication Number Publication Date
HK1007435A1 true HK1007435A1 (en) 1999-04-09

Family

ID=26228598

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106615A HK1007435A1 (en) 1991-03-29 1998-06-25 Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms

Country Status (14)

Country Link
US (1) US5652123A (xx)
EP (1) EP0506574B1 (xx)
JP (1) JP2865423B2 (xx)
AT (1) ATE130869T1 (xx)
CA (1) CA2083826C (xx)
DE (2) DE506574T1 (xx)
DK (1) DK0506574T3 (xx)
ES (1) ES2054601T3 (xx)
GR (2) GR940300052T1 (xx)
HK (1) HK1007435A1 (xx)
HU (2) HU217099B (xx)
IE (1) IE72165B1 (xx)
MD (1) MD1652G2 (xx)
WO (1) WO1992017586A1 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596072A (en) * 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
CA2142860A1 (en) * 1992-08-21 1994-03-03 Gregorio Aversa Human interleukin-13
US6274711B1 (en) 1993-06-14 2001-08-14 Inserm, Institut National De La Sante Et De La Recherche Medicale Purified mammalian CTLA-8 antigens and related reagents
EP0809694B1 (en) * 1995-02-10 2005-12-21 Novozymes A/S Bacillus proteases
AU4534796A (en) * 1995-02-10 1996-08-27 Novo Nordisk A/S Bacillus proteases
US6576232B1 (en) * 1998-04-03 2003-06-10 The Penn State Research Foundation IL13 mutants
CN1352686A (zh) 1998-12-14 2002-06-05 遗传学院有限公司 细胞因子受体链
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
AU2001253282A1 (en) 2000-04-07 2001-10-23 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
US20050059024A1 (en) * 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
SG10201404273QA (en) 2003-12-23 2014-10-30 Genentech Inc Novel anti-il 13 antibodies and uses thereof
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
CA2587903A1 (en) 2004-11-17 2006-05-26 Amgen Fremont Inc. Fully human monoclonal antibodies to il-13
WO2006124451A2 (en) * 2005-05-11 2006-11-23 Centocor, Inc. Anti-il-13 antibodies, compositions, methods and uses
WO2007036745A2 (en) 2005-09-30 2007-04-05 Medimmune Limited Interleukin-13 antibody composition
EP3910065A1 (en) * 2006-09-08 2021-11-17 AbbVie Bahamas Ltd. Interleukin -13 binding proteins
CA2685123A1 (en) * 2007-04-23 2008-10-30 Wyeth Methods and compositions for treating and monitoring treatment of il-13-associated disorders
AU2009283008A1 (en) * 2008-08-20 2010-02-25 Centocor Ortho Biotech Inc. Engineered anti-IL-13 antibodies, compositions, methods and uses
GB0904214D0 (en) 2009-03-11 2009-04-22 Ucb Pharma Sa Biological products
FR2957799B1 (fr) * 2010-03-26 2012-08-17 Inst Des Vaisseaux Et Du Sang Compositions proangiogeniques, leur procede de preparation et leurs utilisations
KR102260855B1 (ko) 2013-09-13 2021-06-04 제넨테크, 인크. 세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법
MX382393B (es) 2013-09-13 2025-03-13 Genentech Inc Métodos y composiciones que comprenden polipéptidos recombinantes purificados.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Also Published As

Publication number Publication date
HU9203753D0 (en) 1993-03-29
MD1652G2 (ro) 2001-12-31
US5652123A (en) 1997-07-29
MD970099A (en) 1998-04-30
IE921016A1 (en) 1992-10-07
EP0506574A1 (fr) 1992-09-30
GR940300052T1 (en) 1994-08-31
CA2083826A1 (en) 1992-09-30
GR3019043T3 (en) 1996-05-31
ATE130869T1 (de) 1995-12-15
HU217099B (hu) 1999-11-29
DE69206301D1 (de) 1996-01-11
EP0506574B1 (fr) 1995-11-29
ES2054601T3 (es) 1996-04-01
HUT68162A (en) 1995-05-29
JP2865423B2 (ja) 1999-03-08
WO1992017586A1 (fr) 1992-10-15
DE506574T1 (de) 1994-11-17
ES2054601T1 (es) 1994-08-16
IE72165B1 (en) 1997-03-26
JPH06500567A (ja) 1994-01-20
MD1652F2 (en) 2001-04-30
CA2083826C (en) 1999-04-27
DK0506574T3 (da) 1996-04-09
DE69206301T2 (de) 1996-06-13

Similar Documents

Publication Publication Date Title
GR940300052T1 (en) Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
AU7587696A (en) Differentiation-suppressive polypeptide
IL68790A (en) Polydeoxyribonucleotide coding for ifn-alpha2(arg),plasmid containing it,cloning of said plasmid and microorganisms containing it and ifn-alpha(arg)encoded by said polydeoxyribonucleotide and its preparation
AU5233686A (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
EP0479071A3 (en) Polypeptide
AU1384995A (en) Human circulating cytokine cc-1
CA2253006A1 (en) .beta.-carotene hydroxylase gene
AU2280192A (en) Recombinant dna coding for a protein with endochitinase activity
AU5520390A (en) Dna coding for protein capable of combining with enhancer of alpha-fetoprotein gene
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
AU2898995A (en) Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant
AU7508694A (en) Novel tyrosine kinase
SG109959A1 (en) 5-substituted hydantoin recemase, dna coding for the same, recombinant dna, transformed cells, and process for producing optically active amino acids
EP0384731A3 (en) Osteogenic growth polypeptides identified from regenerating bone marrow
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
AU2043597A (en) Human taki dna encoding the same
NZ505350A (en) DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours
DE69534738D1 (de) Leukocyten-aktivierender Faktor
CA2244928A1 (en) Dna coding for serine/threonine kinase
EP1013665A4 (en) NEW POLYPEPTIDE DEPLOYING WATER CIRCULATION ACTIVITY AND DNA SEQUENCE
EP1295943A4 (en) POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES
WO2000074629A3 (fr) Composition destinee a la mise en oeuvre d'un traitement cytotoxique, notamment antitumoral ou antiviral, chez un mammifere
AU654155B2 (en) A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene
AU3651997A (en) Constructs and complexes of cyclin e

Legal Events

Date Code Title Description
PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PE Patent expired

Effective date: 20120326